Xpert(R) Flu A Panel Identifies the 2009 H1N1 Influenza Virus in Less Than One Hour SUNNYVALE — Cepheid (Nasdaq: CPHD) today announced it has been granted Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Xpert® Flu A Panel test. The test, which runs on Cepheid’s GeneXpert® System, identifies the […]
FDA Authorizes Emergency Use of Assay for the Detection and Differentiation of the 2009 H1N1 Influenza A Virus SANTA CLARA, Calif. & POTOMAC FALLS, Va.–TessArae, LLC, a privately held company, and Affymetrix Inc., (NASDAQ:AFFX) today announced that the Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to TessArae for its TessArray® Resequencing […]
HUNTINGTON BEACH, California and AMSTERDAM — Agendia, a world leader in molecular cancer diagnostics, announced today that the US Food and Drug Administration (FDA) cleared its MammaPrint breast cancer recurrence test for all ages. MammaPrint is the only FDA-cleared breast cancer recurrence test available to patients and physicians. Over the past three years, the FDA […]
Low-level Mitochondrial DNA Variants are Linked to Disease OMAHA, Neb., December 17, 2009 – Transgenomic, Inc. (OTC BB: TBIO.OB) announced today that it has reached agreement with Gene Solutions for an exclusive licensing option to a set of validated mutations found in Parkinson’s disease patients that can form the basis of a novel and accurate […]
HOUSTON — John Howell, CEO of Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin Board: ARYC), today formally commented on the anticipated timeline for commercialization of its microarray-based OvaDx™ Pre-Symptomatic Ovarian Cancer Blood Test, which is currently advancing through late-stage development – the rights to which have been assigned exclusively to the […]
• The 2009 guidance for the underlying continued and discontinued businesses is unchanged • Exiqon Life Sciences is expected to be cash flow positive in 2010 • Long term financial goal of reaching profitability by 2011 with current capital is maintained. Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”) today announced that it has started a process […]
Investigation Leads the Company to Believe Sequenom Willfully Manipulated its Down Syndrome Data in its Presentations NEW YORK–Xenomics, Inc. (XNOM.PK), a developer of transrenal molecular diagnostics, announced today that an ongoing internal investigation by Xenomics’ personnel of the events surrounding its licensing deal with Sequenom (Nasdaq:SQNM) in late October, 2008 leads it to conclude that […]
The Smallest, Most Economic Array Reader on the Market MUKILTEO, Wash., Dec. 16, 2009 — CombiMatrix Corporation (Nasdaq:CBMX) announced today the launch of its next-generation ElectraSense(R) microarray reader. The new ElectraSense(R) provides a robust, affordable, and user-friendly microarray reader that electrochemically measures up to 12,000 probes on an array in less than 25 seconds. The […]
Optical biosensor uses tiny laser to detect range of pathogens LOS ALAMOS, New Mexico — Los Alamos National Laboratory has executed an agreement with Biomagnetics Diagnostics Corporation (BMGP) for the further development of a diagnostic tool known as an optical biosensor. Los Alamos, whose staff developed the prototype bench-top and hand-held biosensors for the detection […]
Groundbreaking 4.5kg “Lab in a Box(TM)” to Provide Fast H1N1 Virus Detection ST. GEORGE, Utah. — DxNA announced today that the United States Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its 2009 H1N1 influenza virus diagnostic test for use in DxNA’s GeneSTAT(TM) detection platform. The new platform enables fast detection […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
